Your browser doesn't support javascript.
The potential role of TNFα in 2019 novel coronavirus pneumonia.
Ye, Wenjing; Lu, Saisai; Xue, Ali.
  • Ye W; Rheumatology Department, Huashan Hospital, Fudan University, Shanghai, China.
  • Lu S; Rheumatology Department, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
  • Xue A; Hematology and Rheumatology Department, Ruian City People's Hospital, Ruian, China.
Respir Med Case Rep ; 30: 101087, 2020.
Article in English | MEDLINE | ID: covidwho-309395
ABSTRACT
The outbreak of 2019 novel coronavirus has spread rapidly in multiple countries. We report the first case of 2019-nCoV infection in a patient with Ankylosing Spondylitis (AS), who was a biological agent (anti-TNFα) user in Wenzhou, China, and describe the clinical course and management of the case.
Keywords
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Type of study: Case report / Prognostic study Language: English Journal: Respir Med Case Rep Year: 2020 Document Type: Article Affiliation country: J.rmcr.2020.101087

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Type of study: Case report / Prognostic study Language: English Journal: Respir Med Case Rep Year: 2020 Document Type: Article Affiliation country: J.rmcr.2020.101087